American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

U.S. health officials are reviewing the $590M deal for bird flu shots that the Biden administration awarded to Moderna (MRNA) in January, ...

Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...

Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.